| Primary |
| Hypertonic Bladder |
34.6% |
| Hypertension |
15.4% |
| Urinary Incontinence |
4.8% |
| Osteoarthritis |
3.8% |
| Osteoporosis |
3.8% |
| Prophylaxis |
3.8% |
| Angina Pectoris |
2.9% |
| Constipation |
2.9% |
| Dry Eye |
2.9% |
| Hyperlipidaemia |
2.9% |
| Hyperuricaemia |
2.9% |
| Micturition Urgency |
2.9% |
| Seborrhoeic Dermatitis |
2.9% |
| Coronary Artery Disease |
1.9% |
| Dyslipidaemia |
1.9% |
| Foetal Exposure During Pregnancy |
1.9% |
| Gastritis |
1.9% |
| Gastritis Prophylaxis |
1.9% |
| Overactive Bladder |
1.9% |
| Prophylaxis Urinary Tract Infection |
1.9% |
|
| Glomerular Filtration Rate Decreased |
10.7% |
| No Adverse Event |
7.1% |
| Off Label Use |
7.1% |
| Orthostatic Hypotension |
7.1% |
| Osteoarthritis |
7.1% |
| Pulmonary Fibrosis |
7.1% |
| Renal Failure Acute |
7.1% |
| Ageusia |
3.6% |
| Anuria |
3.6% |
| Atrial Fibrillation |
3.6% |
| Blood Uric Acid Increased |
3.6% |
| Cervix Carcinoma Stage 0 |
3.6% |
| Cholecystitis Acute |
3.6% |
| Circulatory Collapse |
3.6% |
| Cognitive Disorder |
3.6% |
| Completed Suicide |
3.6% |
| Cystopexy |
3.6% |
| Dementia |
3.6% |
| Dry Mouth |
3.6% |
| Dyskinesia |
3.6% |
|
| Secondary |
| Product Used For Unknown Indication |
52.8% |
| Hypertonic Bladder |
12.9% |
| Benign Prostatic Hyperplasia |
5.9% |
| Residual Urine |
4.5% |
| Parkinson's Disease |
4.2% |
| Suicide Attempt |
2.8% |
| Drug Use For Unknown Indication |
2.5% |
| Pneumonia |
2.2% |
| Urinary Tract Disorder |
2.2% |
| Urinary Incontinence |
1.7% |
| Hypertension |
1.4% |
| Prostatomegaly |
1.1% |
| Psoriasis |
1.1% |
| Angina Pectoris |
0.8% |
| Depression |
0.8% |
| Hyperlipidaemia |
0.8% |
| Dementia |
0.6% |
| Dyslipidaemia |
0.6% |
| Micturition Urgency |
0.6% |
| Bladder Disorder |
0.3% |
|
| Residual Urine |
21.6% |
| Completed Suicide |
20.3% |
| Transient Ischaemic Attack |
10.8% |
| Toxicity To Various Agents |
9.5% |
| Interstitial Lung Disease |
4.1% |
| Blood Potassium Increased |
2.7% |
| Cervix Carcinoma Stage 0 |
2.7% |
| Drug Toxicity |
2.7% |
| Dyspepsia |
2.7% |
| Eye Disorder |
2.7% |
| Intervertebral Disc Protrusion |
2.7% |
| Loss Of Consciousness |
2.7% |
| Nocturia |
2.7% |
| Orthostatic Hypotension |
2.7% |
| Urinary Tract Infection |
2.7% |
| Abdominal Distension |
1.4% |
| Conjunctival Deposit |
1.4% |
| Death |
1.4% |
| Drug Abuse |
1.4% |
| Drug Hypersensitivity |
1.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
37.9% |
| Drug Use For Unknown Indication |
15.1% |
| Hypertension |
6.6% |
| Prophylaxis |
4.6% |
| Rheumatoid Arthritis |
2.9% |
| Depression |
2.8% |
| Muscle Spasms |
2.7% |
| Diabetes Mellitus |
2.6% |
| Angina Pectoris |
2.5% |
| Cardiac Disorder |
2.5% |
| B-cell Lymphoma |
2.4% |
| Urinary Tract Infection |
2.2% |
| Pain |
2.0% |
| Prostate Cancer |
2.0% |
| Multiple Sclerosis |
1.9% |
| Osteoporosis |
1.9% |
| Psychotic Disorder |
1.9% |
| Bladder Disorder |
1.8% |
| Blood Cholesterol Increased |
1.8% |
| Constipation |
1.8% |
|
| Weight Increased |
12.4% |
| Pancreatitis Acute |
7.4% |
| Malaise |
6.6% |
| Somnolence |
6.6% |
| Urinary Tract Infection |
6.6% |
| Urosepsis |
6.6% |
| Delusion |
5.0% |
| Pain In Extremity |
5.0% |
| Vomiting |
5.0% |
| Death |
4.1% |
| Dysphagia |
4.1% |
| Hypogammaglobulinaemia |
4.1% |
| Medication Residue |
4.1% |
| Sepsis |
4.1% |
| Systolic Hypertension |
4.1% |
| Hyponatraemia |
3.3% |
| Psoriasis |
3.3% |
| Circulatory Collapse |
2.5% |
| Drug Ineffective |
2.5% |
| Dyspnoea |
2.5% |
|
| Interacting |
| Dyspepsia |
50.0% |
| Urinary Incontinence |
50.0% |
|
| Urinary Incontinence |
100.0% |
|
